Clinical Trial Update: Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of pentostatin with low-dose total body irradiation followed by allogeneic peripheral blood stem cell tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Lymphocytic Leukemia

Drugs mentioned

• Allogeneic Peripheral Blood Stem Cell Transplant
• Low-dose total body irradiation (total body irradiation)
• Pentostatin (pentostatin)

Snippet

Sponsor: University of Nebraska | Conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2010-11-17